Dataset Name,Image Name,Characteristics [Organism],Term Source 1 REF,Term Source 1 Accession,Characteristics [Strain],Term Source 2 REF,Term Source 2 Accession,Characteristics [Sex],Term Source 3 REF,Term Source 3 Accession,Characteristics [Age],Characteristics [Individual],Characteristics [Organism Part],Characteristics [Clinical Information],Experimental Condition [Individual],Experimental Condition [Treatment Timepoint],Experimental Condition [Treatment],Experimental Condition [Sampling Timepoint],Comment [Raw Data Capture],Comment [Field],Channels,Comment [Image File Type],Has Phenotype,Phenotype Annotation Level,Phenotype 1,Phenotype 1 Term Name,Phenotype 1 Term Accession,Phenotype 2,Phenotype 2 Term Name,Phenotype 2 Term Accession,Phenotype 3,Phenotype 4,Phenotype 4 Term Name,Phenotype 4 Term Accession,Phenotype 5,Phenotype 5 Term Name,Phenotype 5 Term Accession,Phenotype 6,Phenotype 7,Phenotype 8
TreatStartDay3_Control_Day3PostTreat_mouse50,3.50.6-3.140922_11-36-07.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,3.50.6-3.140922_11-36-07.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,3.50.6-3.140922_11-36-07.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,3.50.6-3.140922_11-36-07.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,3.50.6-3.140922_11-36-07.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,Pos 00_all Ch_all TP_3D registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,Pos 01_all Ch_all TP_3D registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,Pos 02_all Ch_all TP_3D registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,Pos 03_all Ch_all TP_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse50,Pos 04_all Ch_all TP_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 50,tumor,OVA expressing tumor,mouse 50,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,3.55.6-3.140922_15-36-34.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,3.55.6-3.140922_15-36-34.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,3.55.6-3.140922_15-36-34.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,3.55.6-3.140922_15-36-34.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,3.55.6-3.140922_15-36-34.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse55,Pos 04_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 55,tumor,OVA expressing tumor,mouse 55,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_15-41-29.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_15-41-29.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_15-41-29.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_15-41-29.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_15-41-29.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_17-15-27.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_17-15-27.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_17-15-27.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_17-15-27.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,3.66.6-3.141020_17-15-27.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 00_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 01_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 02_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 03_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 04_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 2,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 00_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 01_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 02_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 03_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse66,Pos 04_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 2 of 2,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,3.67.6-3.141020_11-39-56.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,3.67.6-3.141020_11-39-56.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,3.67.6-3.141020_11-39-56.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,3.67.6-3.141020_11-39-56.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,3.67.6-3.141020_11-39-56.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,Pos 00_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,Pos 01_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,Pos 02_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,Pos 03_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day3PostTreat_mouse67,Pos 04_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_15-41-29.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_15-41-29.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_15-41-29.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_15-41-29.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_15-41-29.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141023_15-49-01.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141023_15-49-01.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141023_15-49-01.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141023_15-49-01.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141023_15-49-01.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_17-15-27.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_17-15-27.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_17-15-27.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_17-15-27.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,3.66.9-6.141020_17-15-27.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 00_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 01_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 02_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 03_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 04_all Ch_TP 0-36_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 3,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 04_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 2 of 3,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 00_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 01_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 02_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 03_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse66,Pos 04_all Ch_TP 0-30.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 66,tumor,OVA expressing tumor,mouse 66,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 3 of 3,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,3.67.9-6.141023_12-39-26.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,3.67.9-6.141023_12-39-26.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,3.67.9-6.141023_12-39-26.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,3.67.9-6.141023_12-39-26.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,3.67.9-6.141023_12-39-26.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,Pos 00_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,Pos 01_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,Pos 02_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,Pos 03_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_Control_Day6PostTreat_mouse67,Pos 04_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 67,tumor,OVA expressing tumor,mouse 67,3 days after tumor inoculation,control - cytotoxic T lymphocytes only,6 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_11-33-57.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_11-33-57.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_11-33-57.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_11-33-57.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_13-02-44.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_13-02-44.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_13-02-44.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,3.49.6-3.140922_13-02-44.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei);FD6_FDRED:SHG (collagen)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 00_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 01_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 02_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 03_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 02_all Ch_all TP_registered.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse49,Pos 03_all Ch_all TP_registered.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 49,tumor,OVA expressing tumor,mouse 49,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,3.57.6-3.140922_15-20-05.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,3.57.6-3.140922_15-20-05.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,3.57.6-3.140922_15-20-05.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,3.57.6-3.140922_15-20-05.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,Pos 00_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,Pos 01_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,Pos 02_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse57,Pos 03_all Ch_all TP.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 57,tumor,OVA expressing tumor,mouse 57,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,3.64.6-3.NONE.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,3.64.6-3.NONE.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,3.64.6-3.NONE.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,3.64.6-3.NONE.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,3.64.6-3.NONE.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,Pos 00_all Ch_TP 0-65_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,Pos 01_all Ch_TP 0-65_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,Pos 02_all Ch_TP 0-65.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,Pos 03_all Ch_TP 0-65_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse64,Pos 04_all Ch_TP 0-65_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_15-39-00.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_15-39-00.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_15-39-00.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_15-39-00.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_15-39-00.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_17-15-07.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_17-15-07.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_17-15-07.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_17-15-07.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,3.65.6-3.141020_17-15-07.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 00_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 01_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 02_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 03_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 04_all Ch_TP 0-36_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 2,5,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 00_all Ch_TP 0-42_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 01_all Ch_TP 0-42_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 02_all Ch_TP 0-42_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 03_all Ch_TP 0-42_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day3PostTreat_mouse65,Pos 04_all Ch_TP 0-42_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 2 of 2,5,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,3.64.9-6.141023_12-21-30.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,3.64.9-6.141023_12-21-30.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,3.64.9-6.141023_12-21-30.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,3.64.9-6.141023_12-21-30.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,3.64.9-6.141023_12-21-30.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,Pos 01_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,Pos 02_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,Pos 03_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse64,Pos 04_all Ch_all TP_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 64,tumor,OVA expressing tumor,mouse 64,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,3.65.9-6.141023_15-45-09.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,3.65.9-6.141023_15-45-09.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,3.65.9-6.141023_15-45-09.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,3.65.9-6.141023_15-45-09.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,3.65.9-6.141023_15-45-09.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,Pos 00_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,Pos 01_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,Pos 02_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,Pos 03_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay3_CTL_anti-CD137_Day6PostTreat_mouse65,Pos 04_all Ch_all TP_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 65,tumor,OVA expressing tumor,mouse 65,3 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,6 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,reduced tumor growth,decreased tumor growth/size,MP_0003447,reduced CTL speed,decreased cell movement speed,CMPO_0000240,increased CTL confinement,enhanced CTL killing,T cell mediated killing against a tumor cell phenotype,CMPO_0000449,enhanced CTL proliferation,proliferating cells,CMPO_0000241,enhanced CTL density,,
TreatStartDay7_Control_Day3PostTreat_mouse51,7.51.10-3.140926_10-43-58.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,7.51.10-3.140926_10-43-58.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,7.51.10-3.140926_10-43-58.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,7.51.10-3.140926_10-43-58.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,7.51.10-3.140926_10-43-58.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse51,Pos 04_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 51,tumor,OVA expressing tumor,mouse 51,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,7.52.10-3.140926_14-51-38.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,7.52.10-3.140926_14-51-38.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,7.52.10-3.140926_14-51-38.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,7.52.10-3.140926_14-51-38.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,7.52.10-3.140926_14-51-38.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse52,Pos 04_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 52,tumor,OVA expressing tumor,mouse 52,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,7.53.10-3.140926_18-40-48.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,7.53.10-3.140926_18-40-48.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,7.53.10-3.140926_18-40-48.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,7.53.10-3.140926_18-40-48.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,7.53.10-3.140926_18-40-48.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,1,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,2,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,3,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,4,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_Control_Day3PostTreat_mouse53,Pos 04_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 53,tumor,OVA expressing tumor,mouse 53,7 days after tumor inoculation,control - cytotoxic T lymphocytes only,3 days after treatment start,part 1 of 1,5,RGB,processed,,,,,,,,,,,,,,,,,,
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,7.48.10-3.140926_12-18-43.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,7.48.10-3.140926_12-18-43.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,7.48.10-3.140926_12-18-43.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,7.48.10-3.140926_12-18-43.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,7.48.10-3.140926_12-18-43.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,Pos 00_all Ch_TP 0-34_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,Pos 01_all Ch_TP 0-34_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,Pos 02_all Ch_TP 0-34_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,Pos 03_all Ch_TP 0-34_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse48,Pos 04_all Ch_TP 0-34_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 48,tumor,OVA expressing tumor,mouse 48,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,7.54.10-3.140926_18-36-07.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,7.54.10-3.140926_18-36-07.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,7.54.10-3.140926_18-36-07.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,7.54.10-3.140926_18-36-07.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,7.54.10-3.140926_18-36-07.04.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,"BD2_GREEN:dsRed2 (CTL);FD6_FDRED:SHG (collagen);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_DEEPR:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 00_all Ch_TP 0-37_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 00_all Ch_TP 50-74_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 01_all Ch_TP 0-37_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 01_all Ch_TP 50-74_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 02_all Ch_TP 0-37_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 02_all Ch_TP 50-74_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 03_all Ch_TP 0-37_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 03_all Ch_TP 50-74_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 04_all Ch_TP 0-37_registered_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse54,Pos 04_all Ch_TP 50-74_reg_crop.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 54,tumor,OVA expressing tumor,mouse 54,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,5,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,7.56.10-3.140926_14-52-18.00.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,7.56.10-3.140926_14-52-18.01.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,7.56.10-3.140926_14-52-18.02.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,7.56.10-3.140926_14-52-18.03.pattern,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,"FD5_BLUE:SHG (collagen);FD6_GREEN:dsRed2 (CTL);BD7_RED:Alexa750 (vessels, 70kDa-dextran);BD8_RED:mCherry(Histone-2B-mCherry, B16F10/OVA nuclei)",raw,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,Pos 00_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,1,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,Pos 01_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,2,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,Pos 02_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,3,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density
TreatStartDay7_CTL_anti-CD137_Day3PostTreat_mouse56,Pos 03_all Ch_all TP_registered_cropped.tif,Mus musculus,NCBITaxon,NCBITaxon_10090,C57BL/6J,EFO,EFO_0000606,male,PATO,PATO_0000384,8 to 14 week old,mouse 56,tumor,OVA expressing tumor,mouse 56,7 days after tumor inoculation,cytotoxic T lymphocytes + anti-CD137,3 days after treatment start,part 1 of 1,4,RGB,processed,yes,experimental condition,,,,,,,,,,,,,,,vessel normalization,transient increase in CTL density